Compare GTLB & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GTLB | CGC |
|---|---|---|
| Founded | 2011 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 427.4M |
| IPO Year | 2021 | N/A |
| Metric | GTLB | CGC |
|---|---|---|
| Price | $38.77 | $1.78 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 27 | 2 |
| Target Price | ★ $54.59 | N/A |
| AVG Volume (30 Days) | 5.5M | ★ 27.0M |
| Earning Date | 12-02-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $906,253,000.00 | $200,022,256.00 |
| Revenue This Year | $26.43 | $6.79 |
| Revenue Next Year | $20.01 | $7.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.36 | N/A |
| 52 Week Low | $35.81 | $0.77 |
| 52 Week High | $74.18 | $3.26 |
| Indicator | GTLB | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 39.40 | 71.02 |
| Support Level | $35.81 | $1.10 |
| Resistance Level | $41.55 | $1.18 |
| Average True Range (ATR) | 1.66 | 0.11 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 37.12 | 75.95 |
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.